An embolic material contains at least one type of polymer and a liposoluble contrast medium. A method for producing an embolic material includes extruding a raw material that is in a molten state into a solvent, and cooling the raw material so as to solidify the raw material. The raw material contains a polymer and a liposoluble contrast medium.

Described are amphiphilic polymers that are provided with chelating moieties. The amphiphilic polymers are block copolymers comprising a hydrophilic block and a hydrophobic block, with the chelating moieties linked to the end-group of the hydrophilic block. The disclosed polymers are capable of self-assembly into structures such as micelles and polymersomes. With suitable metals present in the form of coordination complexes with the chelating moieties, the chelating amphiphilic polymers of the invention are suitable for use in various imaging techniques requiring metal labeling, such as MRI (T.sub.1/T.sub.2 weighted contrast agents or CEST contrast agents) SPECT, PET or Spectral CT.

Dental contrast formulations (“fillers”) of tailorable X-Ray radiopacity and methods for their use are provided. The disclosed fillers include mixtures of solid particles suspended in a biocompatible fluid. The solid particles contain one or more X-ray radiopaque materials. The biocompatible fluid can also contain one or more soluble X-ray radiopaque components. By controlling the composition of the solid particles, the composition of the biocompatible fluid, and the loading of the solid particles in the biocompatible fluid, the X-ray radiopacity and stability of the filler can be tailored to allow for improved discrimination of the filler within periodontal pockets, relative to adjacent soft tissue and teeth, so that the 3-D shape, volume, and depth of the pocket can be precisely and rapidly determined by X-Ray imaging.

The present invention provides particulate contrast media for use in CT imaging. In an exemplary embodiment, the invention provides an enteric contrast medium formulation based on particles of low-Z elements selected from microparticles and nanoparticles. In various embodiments, the particles are coated with a material compatible with enteric administration of the formulation to a subject in need of such administration. The invention also provides methods for imaging of body parts simultaneously enhanced with contrast media of the invention and with other contrast media of a different type using CT imaging, including dual energy or spectral CT imaging. The invention also provides methods for the digital separation of CT signal produced by the contrast media of the invention from the CT signal produced by other contrast media or bodily tissues, to generate multiple resultant CT images with individual contrast materials subtracted or highlighted.

A capsule for measuring motility of a target area and a method for making the capsule are provided. The capsule comprises a capsule enclosure and a plurality of identification markers to be placed inside of the capsule enclosure. Each identification marker has a weight of W.sub.m, being comprised of a first element, which can be visible and imaged under X-ray, having a weight of W.sub.1. Each identification marker comprises a second element, which cannot be imaged under X-ray, having a weight of W.sub.2; and a third element, which is a number of cavities. When the first element is viewed under X-ray, at least two views of the first element is identical. The weight of each identification marker W.sub.m=W.sub.1+W.sub.2; and when there is a weight change in the first element or in the second element, the shape, number and/or sizes of the cavities are adjusted and accommodated so that the weight of the identification marker is at a target value, which characterized by that each identification marker has a density between 1.0-1.7 g/cm.sup.3.

An embolic material contains at least one type of polymer and a liposoluble contrast medium. A method for producing an embolic material includes extruding a raw material that is in a molten state into a solvent, and cooling the raw material so as to solidify the raw material. The raw material contains a polymer and a liposoluble contrast medium.

The present invention relates to compositions and methods for use in medical diagnosis and patient monitoring, typically in the context of therapy, in particular in the context of oncology, to optimize tumor bed local irradiation. It more particularly relates to a biocompatible gel comprising nanoparticle and/or nanoparticle aggregates, wherein: i) the density of each nanoparticle and of each nanoparticle aggregate is at least 7 g/cm.sup.3, the nanoparticle or nanoparticles of the aggregate comprising an inorganic material comprising at least one metal element having an atomic number Z of at least 25, more preferably of at least 40, each of said nanoparticle and nanoparticle aggregate being covered with a biocompatible coating; ii) the nanoparticles' and/or nanoparticle aggregates' concentration is of at least about 1% (w/w); and iii) the apparent viscosity at 2 s.sup.1 of the gel comprising nanoparticles and/or nanoparticle aggregates is between about 0.1 Pa.Math.s and about 1000 Pa.Math.s when measured between 20 C. and 37 C.

A dispersion for an X-ray target in which gold nanoparticles and sodium alginate or a calcium phosphate-based bone reinforcing material are dispersed, in which the gold nanoparticles are in contact with the sodium alginate or the calcium phosphate-based bone reinforcing material.

A capsule for measuring motility of a target area and a method for making the capsule are provided. The capsule comprises a capsule enclosure and a plurality of identification markers to be placed inside of the capsule enclosure. Each identification marker has a weight of W.sub.m, being comprised of a first element, which can be visible and imaged under X-ray, having a weight of W.sub.1. Each identification marker comprises a second element, which cannot be imaged under X-ray, having a weight of W.sub.2; and a third element, which is a number of cavities. When the first element is viewed under X-ray, at least two views of the first element is identical. The weight of each identification marker W.sub.m=W.sub.1+W.sub.2; and when there is a weight change in the first element or in the second element, the shape, number and/or sizes of the cavities are adjusted and accommodated so that the weight of the identification marker is at a target value, which characterized by that each identification marker has a density between 1.0-1.7 g/cm.sup.3.

Radiopaque bismuth particles and methods of making and using the radiopaque bismuth particles are disclosed. The radiopaque bismuth particles include an elemental bismuth core and an outer coating comprising one or more coating agents. Disclosed radiopaque bismuth particles are suitable for use in surgical sponges and plastic objects.